91 related articles for article (PubMed ID: 23352270)
41. The role of intensive insulin therapy in increasing superoxide dismutase (SOD) and normalizing hyperglycemia in critically ill patients.
Wiryana M
Acta Med Indones; 2009 Apr; 41(2):59-65. PubMed ID: 19390123
[TBL] [Abstract][Full Text] [Related]
42. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients.
der Voort PH; Feenstra RA; Bakker AJ; Heide L; Boerma EC; van der Horst IC
Clin Endocrinol (Oxf); 2006 Feb; 64(2):141-5. PubMed ID: 16430711
[TBL] [Abstract][Full Text] [Related]
43. Caffeic acid attenuates neuronal damage, astrogliosis and glial scar formation in mouse brain with cryoinjury.
Zhang L; Zhang WP; Chen KD; Qian XD; Fang SH; Wei EQ
Life Sci; 2007 Jan; 80(6):530-7. PubMed ID: 17074364
[TBL] [Abstract][Full Text] [Related]
44. The effects of critical illness on intestinal glucose sensing, transporters, and absorption.
Deane AM; Rayner CK; Keeshan A; Cvijanovic N; Marino Z; Nguyen NQ; Chia B; Summers MJ; Sim JA; van Beek T; Chapman MJ; Horowitz M; Young RL
Crit Care Med; 2014 Jan; 42(1):57-65. PubMed ID: 23963126
[TBL] [Abstract][Full Text] [Related]
45. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.
Marty N; Dallaporta M; Foretz M; Emery M; Tarussio D; Bady I; Binnert C; Beermann F; Thorens B
J Clin Invest; 2005 Dec; 115(12):3545-53. PubMed ID: 16322792
[TBL] [Abstract][Full Text] [Related]
46. [Insulin infusion for critically ill patients].
Skeie S; Søreide E; Cooper J
Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2378-81. PubMed ID: 17895943
[TBL] [Abstract][Full Text] [Related]
47. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients.
Vanhorebeek I; Gunst J; Derde S; Derese I; Boussemaere M; Güiza F; Martinet W; Timmermans JP; D'Hoore A; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2011 Apr; 96(4):E633-45. PubMed ID: 21270330
[TBL] [Abstract][Full Text] [Related]
48. Higher plasma pyridoxal 5'-phosphate is associated with better blood glucose responses in critically ill surgical patients with inadequate vitamin B-6 status.
Hou CT; Wu YH; Huang PN; Cheng CH; Huang YC
Clin Nutr; 2011 Aug; 30(4):478-83. PubMed ID: 21349613
[TBL] [Abstract][Full Text] [Related]
49. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
[TBL] [Abstract][Full Text] [Related]
50. Neuronal damage and gliosis in the somatosensory cortex induced by various durations of transient cerebral ischemia in gerbils.
Lee JC; Ahn JH; Lee DH; Yan BC; Park JH; Kim IH; Cho GS; Kim YM; Lee B; Park CW; Cho JH; Lee HY; Won MH
Brain Res; 2013 May; 1510():78-88. PubMed ID: 23528266
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of human brain damage in fire fatality by quantification of basic fibroblast growth factor (bFGF), glial fibrillary acidic protein (GFAP) and single-stranded DNA (ssDNA) immunoreactivities.
Wang Q; Ishikawa T; Michiue T; Zhu BL; Maeda H
Forensic Sci Int; 2011 Sep; 211(1-3):19-26. PubMed ID: 21530117
[TBL] [Abstract][Full Text] [Related]
52. Glucose metabolism and insulin therapy.
Langouche L; Van den Berghe G
Crit Care Clin; 2006 Jan; 22(1):119-29, vii. PubMed ID: 16399023
[TBL] [Abstract][Full Text] [Related]
53. A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients.
Lin J; Razak NN; Pretty CG; Le Compte A; Docherty P; Parente JD; Shaw GM; Hann CE; Geoffrey Chase J
Comput Methods Programs Biomed; 2011 May; 102(2):192-205. PubMed ID: 21288592
[TBL] [Abstract][Full Text] [Related]
54. [Effect of combined administration of manganese and insulin on glucose utilization].
Boechko FF; Sizonenko GS; Zakharik DM
Ukr Biokhim Zh (1978); 1985; 57(1):85-8. PubMed ID: 3883607
[TBL] [Abstract][Full Text] [Related]
55. Assessment of in vivo glucose kinetics using stable isotope tracers to determine their alteration in humans during critical illness.
Sakurai Y; Ochiai M; Funabiki T
Surg Today; 2000; 30(1):1-10. PubMed ID: 10648075
[TBL] [Abstract][Full Text] [Related]
56. Parenteral glucose and glucose control in the critically ill: a kinetic appraisal.
Hovorka R; Cordingley J
J Diabetes Sci Technol; 2007 May; 1(3):357-65. PubMed ID: 19885090
[TBL] [Abstract][Full Text] [Related]
57. Glucose control in critically ill diabetic: Not so sweet.
Todi SK
Indian J Crit Care Med; 2016 Feb; 20(2):65-6. PubMed ID: 27076704
[No Abstract] [Full Text] [Related]
58. Blood glucose control in the ICU: don't throw out the baby with the bathwater!
Gunst J; Van den Berghe G
Intensive Care Med; 2016 Sep; 42(9):1478-81. PubMed ID: 27161085
[No Abstract] [Full Text] [Related]
59. The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.
Friedrich O; Reid MB; Van den Berghe G; Vanhorebeek I; Hermans G; Rich MM; Larsson L
Physiol Rev; 2015 Jul; 95(3):1025-109. PubMed ID: 26133937
[TBL] [Abstract][Full Text] [Related]
60. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.
Sonneville R; den Hertog HM; Derde S; Güiza F; Derese I; Van den Berghe G; Vanhorebeek I
Clin Nutr; 2013 Dec; 32(6):1077-80. PubMed ID: 23352270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
